Influenza-B Malaysia refers to the influenza B virus strain designated as B/Malaysia/2506/2004, a member of the Victoria lineage. This strain has been pivotal in understanding influenza B evolution, antigenic drift, and vaccine development in tropical regions. First isolated in Malaysia, it has been extensively studied for its genetic makeup, epidemiological impact, and role in global influenza surveillance .
Source: Propagated in embryonated eggs, purified via ultracentrifugation with sucrose gradients .
Stability: Stable for 4 weeks at 4°C but requires long-term storage below -18°C .
Property | Details |
---|---|
Formulation | STE buffer, 0.1% sodium azide, 0.005% thimerosal |
Immunological Use | Immunogen for antibody production; tested with anti-influenza B monoclonal antibodies |
Lineage Shifts: Predominant Victoria and Yamagata lineages cycled every 1–3 years, with B/Malaysia/2506/2004 driving Victoria lineage surges in 2004–2007 .
Seasonality: Peaks observed during March–April, correlating with higher rainfall and humidity .
Pediatric Impact: Responsible for 92% of influenza B cases in children (2004–2006), with higher hospitalization rates in infants aged 2–10 months .
Economic Cost: Influenza B contributed to MYR 310.9 million in healthcare costs over three years (2016–2018) .
Year | Predominant Lineage | Vaccine Match |
---|---|---|
2005 | B/Hong Kong/330/2001 | Mismatch |
2006 | B/Malaysia/2506/2004 | Matched (WHO Northern/Southern Hemisphere) |
2013 | B/Massachusetts/2/2012 | Mismatch |
Vaccine Strain: Adopted as the WHO-recommended influenza B component for 2006–2007 vaccines due to its antigenic distinctiveness .
Challenges: Frequent lineage mismatches occurred post-2007, highlighting the need for continuous surveillance .
Regional Hub: Southeast Asia, including Malaysia, serves as a hotspot for novel influenza B variants due to year-round transmission and high genetic diversity .
Reassortment Events: B/Malaysia/2506/2004-like viruses exhibited intra-clade reassortments, influencing global strain distribution .
Based on comprehensive surveillance data from 2016-2018, Influenza-B demonstrated predominance in 2016, while Influenza-A showed higher prevalence in 2017 and 2018 . Among the 17,416 samples analyzed during this period, 2,620 (15.0%) tested positive for influenza, with substantial variability in subtype distribution across years . The timeline of influenza subtype distributions showed two changes to the predominant type in circulation in 2016 alone: from influenza B to influenza A and then back to B . Researchers should implement longitudinal surveillance studies spanning multiple years to account for inter-annual variability in subtype predominance. Stratified sampling approaches across various healthcare settings (public and private) are essential for representative prevalence estimates.
Research indicates that influenza infections are reported throughout the year in tropical and subtropical Southern and Southeast Asian countries, generally with two significant outbreaks annually . Despite consistent climate conditions across the region, outbreak timing varies considerably between countries . The proximity and extent of contact between people in a location affect the scale of any influenza epidemic, with increased incidence rates in areas where people congregate . Researchers investigating comparative epidemiology should implement harmonized surveillance protocols across multiple countries, with standardized case definitions, laboratory methods, and reporting systems. Phylogenetic analyses of circulating strains can reveal transmission patterns between countries in the region.
Multiple diagnostic approaches are employed across Malaysia's surveillance system, with varying sensitivity levels and turnaround times:
Real-time reverse transcription-polymerase chain reaction (RT-PCR): Considered the gold standard, used by the Institute of Medical Research (IMR), National Public Health Laboratory (NPHL), and KPJ Hospitals for detection and subtyping of influenza viruses, with a turnaround time of 7 days .
Virus isolation: Employed at multiple sites with a longer turnaround time of 21 days .
Immunofluorescence assay: Used particularly at the University of Malaya Medical Center (UMMC), with a turnaround time of approximately 5 days .
The standard specimen types include nasopharyngeal swabs, throat swabs, nasopharyngeal aspirates, and bronchoalveolar lavage . Researchers should consider these methodological variations when comparing data across different surveillance sites and implement standardized testing protocols when designing multi-center studies.
Available evidence suggests significant sensitivity differences between detection methods. The study specifically notes that the lower percentage of samples from UMMC that tested positive for SARI compared to the percentages found in samples from other sites could be attributed to the lack of systematic disease screening such as RT-PCR tests . While UMMC employs immunofluorescence assay followed by virus isolation, other sites use confirmatory PCR diagnostic tests as standard practice . This methodological difference explains substantial variation in positivity rates, with UMMC detecting influenza in only 5.6% of SARI cases compared to 16.1% at IMR and 18.3% at KPJ hospitals . Researchers should implement side-by-side comparisons of different testing methods using standardized specimen panels when conducting diagnostic evaluation studies.
When designing laboratory-based surveillance studies for Influenza-B in Malaysia, researchers should consider:
Standardized specimen collection protocols: Malaysia's surveillance system uses specific guidelines for collecting nasopharyngeal swabs and other respiratory specimens in viral transport media .
Testing algorithm: Design should incorporate appropriate testing workflows as demonstrated in Malaysia's surveillance protocol flow chart, which shows specimen routing from sentinel sites to designated reference laboratories .
Quality control measures: Implementation of internal controls to monitor extraction efficiency and detect PCR inhibition is essential.
Subtyping capabilities: Ensure that laboratory protocols can distinguish between Influenza-B lineages (Victoria and Yamagata), which may have different epidemiological patterns.
Turnaround time: Consider the implications of different laboratory TATs (ranging from 5-21 days depending on method) on real-time surveillance capabilities .
The age distribution of influenza infections in Malaysia shows distinct patterns:
Age Group | ILI Positivity (%) | SARI Positivity (%) |
---|---|---|
<2 years | 7.9% | 7.6% |
2-4 years | 13.3% | 15.5% |
5-14 years | 21.6% | 19.0% |
15-49 years | 15.1% | 18.6% |
50-64 years | 10.8% | 21.0% |
>64 years | 8.1% | 19.0% |
This data reveals that school-age children (5-14 years) had the highest positivity rate for influenza-like illness (ILI), while adults aged 50-64 years had the highest positivity rate for severe acute respiratory infection (SARI) . Researchers investigating age-related patterns should employ age-stratified sampling systems with standardized approaches across all age groups. To address the underrepresentation of elderly populations in surveillance data, targeted sampling strategies are recommended.
Multiple factors influence the variability in influenza subtype predominance in Malaysia:
Population movement and travel: Holiday periods toward the end of the year when many people travel abroad potentially bring new strains upon return .
Population immunity dynamics: Studies from Singapore and Hong Kong have identified negative correlations between waves of seasonal influenza activity and population immune resistance .
Antigenic drift and waning immunity: The interplay of antigenic drift and waning immunity post-infection and/or vaccination likely drives outbreak timing in tropical regions .
Environmental factors: Although less predictable than in temperate regions, environmental conditions may influence virus survival and transmission.
Researchers investigating these factors should design longitudinal seroepidemiological studies that track population immunity alongside circulating strains, using mathematical modeling approaches that incorporate immunity dynamics, virus evolution, and human mobility data.
The cross-sectional study observed a lower frequency of samples from older adults, potentially due to site inaccessibility, reduced mobility, transport issues, lack of motivation to seek treatment, and socioeconomic factors . Researchers aiming to minimize surveillance biases should:
Implement community-based surveillance components to complement facility-based systems.
Design stratified sampling approaches ensuring adequate representation across all demographic groups.
Develop mobile sampling teams that can reach less mobile populations.
Employ capture-recapture methods to estimate the completeness of surveillance systems and adjust for underreporting in specific subpopulations.
Incorporate qualitative research to understand healthcare-seeking behaviors affecting participation in surveillance.
The study utilized multiple methodological approaches to estimate influenza costs:
Malaysia's Diagnosis-Related Group system (MyDRG): This casemix system combines hospitals' clinical and demographic patient data for classification and costing purposes, and was used to establish the estimated financial costs of hospitalized influenza cases .
ICD-10 code mapping: For hospitals without MyDRG implementation (UMMC and KPJ), the relevant ICD-10 codes, length of hospital stay, and other diagnoses were used to produce DRG codes for cost estimation .
Per-patient costing methodology: Outpatient (ILI) treatment costs were estimated using this approach from previous research .
Data triangulation: Information from multiple sources including MOH sentinel sites, teaching hospitals, private medical institutions, and MOH casemix costing was combined to generate comprehensive estimates .
Researchers developing cost-effectiveness analyses for Influenza-B prevention in Malaysia should:
Structure models to reflect Malaysia's healthcare system characteristics, including the public-private mix and financing mechanisms.
Incorporate local data on disease burden, costs, and intervention effectiveness from studies like the cross-sectional research that provided detailed information on influenza positivity rates by age, gender, and healthcare setting .
Include both direct medical costs (using methodologies like the MyDRG system) and indirect societal costs.
Account for Malaysia's year-round influenza circulation pattern with irregular seasonal peaks, which differs from temperate regions .
Consider the consistent surge in Influenza-B incidence during March when modeling intervention timing .
Use transmission dynamic models that capture both direct and indirect (herd) effects of interventions like vaccination.
The study noted that infection control measures implemented during the COVID-19 pandemic had a profound impact on influenza transmission, with notably low influenza incidence during 2020 and 2021 . This natural experiment provides valuable insights for evaluating non-pharmaceutical interventions. Researchers evaluating such interventions should employ:
While the cross-sectional study didn't directly address genomic surveillance, it emphasized that "mapping the distribution and incidence of influenza A and B is pivotal to effective healthcare decisions" . Given the study's observation of changing predominant subtypes over the study period, genomic surveillance would provide valuable data to inform prevention strategies . Researchers implementing genomic surveillance programs should:
Establish systematic sampling frameworks that capture the year-round circulation of influenza in Malaysia.
Focus on periods of increased Influenza-B circulation, particularly the March peak identified in the study .
Integrate genomic data with epidemiological information to correlate genetic changes with transmission patterns.
Compare local genomic data with global patterns to identify potential introduction of novel variants, particularly given the study's mention of holiday travel potentially introducing new strains .
The cross-sectional study demonstrated a comprehensive approach by gathering retrospective data from multiple sources, including MOH influenza sentinel sites, teaching hospitals, and private medical institutions . For researchers planning epidemiological studies on Influenza-B in Malaysia, recommended study designs include:
Longitudinal surveillance studies spanning multiple years to capture the year-to-year variability in influenza subtype predominance demonstrated in the 2016-2018 data .
Targeted sampling during the consistent March peak of Influenza-B identified in the study .
Multi-center designs including both public and private healthcare facilities to ensure representative data, as the study found different positivity rates between sectors .
Age-stratified sampling to adequately represent all demographic groups, particularly addressing the underrepresentation of older adults noted in the study .
Mixed-methods approaches incorporating qualitative elements to understand healthcare-seeking behaviors that may affect surveillance data completeness.
The Malaysian surveillance system utilizes standardized case definitions for influenza-like illness (ILI) and severe acute respiratory infection (SARI), with systematic sample collection from sentinel sites . The surveillance protocol demonstrates a structured approach to case identification and specimen collection, with specific guidance on sampling methodology . Researchers implementing multi-site studies should:
Develop detailed protocols with explicit clinical criteria based on established surveillance definitions.
Standardize laboratory confirmation methods, noting the study's finding that different diagnostic approaches (RT-PCR versus immunofluorescence) yielded significantly different positivity rates .
Implement quality control procedures including periodic reassessment of case definition application.
Consider using standardized electronic data collection tools to ensure consistent application of case definitions.
Given the complex patterns of influenza circulation in Malaysia revealed by the cross-sectional study, researchers should consider several statistical approaches:
Time series analysis: Essential for examining the seasonal patterns and year-to-year variability observed in the study, particularly the consistent March surge in Influenza-B incidence .
Age-stratified analysis: Critical given the significant differences in positivity rates across age groups found in the study, with school-age children showing high ILI positivity rates (21.6%) and adults aged 50-64 showing high SARI positivity rates (21.0%) .
Adjustment for diagnostic method: Statistical approaches should account for the substantial difference in detection rates between different diagnostic methods noted in the study .
Geographic clustering analysis: While not explicitly covered in the study results, the multi-site design suggests potential geographic variations that should be statistically explored .
Trend analysis: Important for examining the changes in predominant subtypes over time, as observed in the study's finding that influenza B was predominant in 2016 while influenza A was more prevalent in 2017 and 2018 .
Influenza B Virus Malaysia/2506/04 is a strain of the Influenza B virus, which is one of the two types of influenza viruses that cause seasonal flu epidemics in humans. Unlike Influenza A, which can infect both humans and animals, Influenza B primarily infects humans and is less prone to cause pandemics. However, it still poses a significant public health concern due to its ability to cause severe respiratory illness, particularly in vulnerable populations such as children and the elderly.
The Influenza B Virus Malaysia/2506/04 strain was first isolated in Malaysia in the year 2004. This strain is part of the Victoria lineage of Influenza B viruses, which are named after the location where they were first identified. The Victoria lineage, along with the Yamagata lineage, represents the two main genetic lineages of Influenza B viruses. The isolation and identification of this strain have contributed to the understanding of the genetic diversity and evolution of Influenza B viruses .
Influenza B Virus Malaysia/2506/04 is an enveloped virus with a diameter of approximately 80-120 nanometers. It contains a single-stranded, segmented, negative-sense RNA genome within a nucleocapsid. The segmented nature of the genome allows for genetic reassortment, which can lead to the emergence of new viral strains. This genetic instability is responsible for the annual epidemics and occasional pandemics of influenza infections .
The hemagglutinin (HA) and neuraminidase (NA) genes of the virus are particularly important for its ability to infect host cells and for the development of immunity. Phylogenetic analyses of these genes have provided valuable insights into the evolution and spread of Influenza B viruses. The HA gene of the Malaysia/2506/04 strain belongs to the B/Victoria/2/87 lineage, while the NA gene belongs to the B/Yamagata/16/88 lineage .
Influenza B Virus Malaysia/2506/04 has been involved in several outbreaks and has been a subject of virological investigations. For instance, during the 2006-2007 influenza season in Taiwan, this strain was identified in multiple outbreaks. The strain was found to be antigenically similar to other B/Malaysia/2506/04-like viruses, and the seasonal influenza vaccine used during that period was effective in stimulating protective immunity against these variants .
Research on Influenza B Virus Malaysia/2506/04 has led to the development of various reagents, including proteins, antibodies, and cDNAs, which are used in scientific studies and vaccine development. The hemagglutinin protein (HA) of this strain, expressed in different host systems such as baculovirus-insect cells and HEK293 cells, has been utilized in the production of vaccines and diagnostic assays .
Continuous surveillance and genetic analysis of Influenza B viruses are crucial for the selection of appropriate vaccine candidates and for the development of effective prophylactic measures. The study of strains like Malaysia/2506/04 helps in understanding the genetic and antigenic diversity of Influenza B viruses, which is essential for the control and prevention of influenza outbreaks.